These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21568231)

  • 21. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.
    Ness-Abramof R; Nabriski D; Apovian CM; Niven M; Weiss E; Shapiro MS; Shenkman L
    Obes Res; 2002 Dec; 10(12):1217-21. PubMed ID: 12490665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of plasma, salivary, and urinary cortisol levels for diagnosis of Cushing's syndrome.
    Sakihara S; Kageyama K; Oki Y; Doi M; Iwasaki Y; Takayasu S; Moriyama T; Terui K; Nigawara T; Hirata Y; Hashimoto K; Suda T
    Endocr J; 2010; 57(4):331-7. PubMed ID: 20139634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 10:00-11:00 pm urine cortisol/creatinine ratio. An alternative to late-night salivary cortisol for the diagnosis of Cushing's syndrome.
    Bruno OD; Rossi MA; Juárez-Allen L; Serra HA; Albiero MC
    Medicina (B Aires); 2015; 75(6):373-8. PubMed ID: 26707659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary free cortisol versus 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing's syndrome.
    Mengden T; Hubmann P; Müller J; Greminger P; Vetter W
    Clin Investig; 1992 Jul; 70(7):545-8. PubMed ID: 1327327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of Cushing's syndrome and subclinical disease.
    Ross NS
    Endocrinol Metab Clin North Am; 1994 Sep; 23(3):539-46. PubMed ID: 7805652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening of Cushing's syndrome in patients with Type 2 diabetes.
    Falhammar H
    N Z Med J; 2008 Jul; 121(1277):100-2. PubMed ID: 18677341
    [No Abstract]   [Full Text] [Related]  

  • 28. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pitfalls in the diagnosis and management of Cushing's syndrome.
    Bansal V; El Asmar N; Selman WR; Arafah BM
    Neurosurg Focus; 2015 Feb; 38(2):E4. PubMed ID: 25639322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salivary cortisol measurement--a reliable method for the diagnosis of Cushing's syndrome.
    Trilck M; Flitsch J; Lüdecke DK; Jung R; Petersenn S
    Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):225-30. PubMed ID: 15891959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pre-clinical Cushing's syndrome: report of a case and the review of the literature].
    Miyamori I; Iki K; Takeda R
    Nihon Naibunpi Gakkai Zasshi; 1994 Jan; 70(1):25-30. PubMed ID: 7958080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concordance of the late night salivary cortisol in patients with Cushing's syndrome and elevated urine-free cortisol.
    Doi SA; Clark J; Russell AW
    Endocrine; 2013 Apr; 43(2):327-33. PubMed ID: 23238876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late-Night Salivary Cortisol: Cut-Off Definition and Diagnostic Accuracy for Cushing's Syndrome in a Portuguese Population.
    Lages AS; Frade JG; Oliveira D; Paiva I; Oliveira P; Rebelo-Marques A; Carrilho F
    Acta Med Port; 2019 May; 32(5):381-387. PubMed ID: 31166899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence, etiology and clinical findings of Cushing's syndrome].
    Lahera Vargas M; da Costa CV
    Endocrinol Nutr; 2009 Jan; 56(1):32-9. PubMed ID: 19627706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overnight (1 mg) dexamethasone suppression testing reliably distinguishes non-cushingoid obesity from Cushing's syndrome.
    Fok AC; Tan KT; Jacob E; Sum CF
    Steroids; 1991 Nov; 56(11):549-51. PubMed ID: 1814020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overnight urinary free cortisol determination: a screening test for the diagnosis of Cushing's syndrome.
    Corcuff JB; Tabarin A; Rashedi M; Duclos M; Roger P; Ducassou D
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):503-8. PubMed ID: 9640418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity of first-line tests for the diagnosis of Cushing's syndrome: assessment in a large series.
    Pecori Giraldi F; Ambrogio AG; De Martin M; Fatti LM; Scacchi M; Cavagnini F
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4123-9. PubMed ID: 17698908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.
    Montwill J; Igoe D; McKenna TJ
    Steroids; 1994 May; 59(5):296-8. PubMed ID: 8073441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occult Cushing's syndrome in type-2 diabetes.
    Catargi B; Rigalleau V; Poussin A; Ronci-Chaix N; Bex V; Vergnot V; Gin H; Roger P; Tabarin A
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5808-13. PubMed ID: 14671173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.